Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 166Active not recruiting 55Recruiting 45Unknown 44Terminated 44Withdrawn 10Not yet recruiting 10Enrolling by invitation 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Neoplasms 1

Interventions

Surgical Procedures, Operative 2Music Therapy 2Letrozole 2Fluorodeoxyglucose F18 2Drug Therapy 2exemestane 1dalpiciclib 1Zoledronic Acid 1Vitamin D 1Tamoxifen 1Synbiotics 1Resistance Training 1Relaxation Therapy 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Prebiotics 1Oxygen Inhalation Therapy 1Neoadjuvant Therapy 1Mastectomy, Segmental 1Mastectomy, Modified Radical 1Mastectomy 1Mannitol 1Magnetic Resonance Imaging 1Interviews as Topic 1Hyperbaric Oxygenation 1Educational Status 1Echocardiography 1Diagnostic Imaging 1Combined Modality Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Breast Neoplasms × Letrozole × Clear all
NCT06650748 2026-03-17

NeoMARS

Peking University

Phase 2 Enrolling by invitation
100 enrolled
Breast

Breast Neoplasms

NCT05645536 2026-01-12

Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

Tolmar Inc.

Phase 3 Enrolling by invitation
250 enrolled
Breast

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡